The US Food and Drug Administration proposed major revisions to the physician labelling for prescription drugs (including biological products) to provide better information about the effects of medicines used during pregnancy and breast-feeding.
According to an US FDA press release, the proposed changes to prescription drug labelling would give health care professionals more comprehensive information for making prescribing decisions and for counselling women who are pregnant, breast-feeding, or of child-bearing age about using prescription medications.
The whole story can be read here.
No comments:
Post a Comment